EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Gnotobiotic Mouse Model with Divergent Equol-Producing Phenotypes: Potential for Determining Microbial-Driven Health Impacts of Soy Isoflavone Daidzein

Lindsay M Leonard, Abigayle M R Simpson iD, Shiyu Li, Lavanya Reddivari, Tzu-Wen L Cross iD

Nutrients · 2024

DOI: 10.3390/nu16071079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Lindsay M Leonard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Science, Purdue University, West Lafayette, IN 47907, USA. Hauptthemen laut MEDLINE: Equol, Isoflavones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Purdue University West Lafayette, College of Agriculture at Purdue University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The implications of soy consumption on human health have been a subject of debate, largely due to the mixed evidence regarding its benefits and potential risks. The variability in responses to soy has been partly attributed to differences in the metabolism of soy isoflavones, compounds with structural similarities to estrogen. Approximately one-third of humans possess gut bacteria capable of converting soy isoflavone daidzein into equol, a metabolite produced exclusively by gut microbiota with significant estrogenic potency. In contrast, lab-raised rodents are efficient equol producers, except for those raised germ-free. This discrepancy raises concerns about the applicability of traditional rodent models to humans. Herein, we designed a gnotobiotic mouse model to differentiate between equol producers and non-producers by introducing synthetic bacterial communities with and without the equol-producing capacity into female and male germ-free mice. These gnotobiotic mice display equol-producing phenotypes consistent with the capacity of the gut microbiota received. Our findings confirm the model’s efficacy in mimicking human equol production capacity, offering a promising tool for future studies to explore the relationship between endogenous equol production and health outcomes like cardiometabolic health and fertility. This approach aims to refine dietary guidelines by considering individual microbiome differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EquolIsoflavonesHumansFemaleMaleAnimalsMiceDisease Models, AnimalKetonesPhenotype

Stichwörter der Autor:innen

daidzeinequolgnotobiotic micemodelsoy isoflavonessynthetic microbiome

Substanzen

EquoldaidzeinIsoflavonesKetones

Autor:innen und Institutionen

  • Department of Nutrition Science, Purdue University, West Lafayette, IN 47907, USA.
  • Department of Food Science, Purdue University, West Lafayette, IN 47907, USA.

ORCID-Profile: Abigayle M R Simpson, Tzu-Wen L Cross

Förderung

  • Purdue University West Lafayette
  • College of Agriculture at Purdue University

Zitieren

APA

Leonard, L. M., Simpson, A. M. R., Li, S., Reddivari, L., & Cross, T. L. (2024). A Gnotobiotic Mouse Model with Divergent Equol-Producing Phenotypes: Potential for Determining Microbial-Driven Health Impacts of Soy Isoflavone Daidzein. Nutrients. https://doi.org/10.3390/nu16071079

Vancouver

Leonard LM, Simpson AMR, Li S, Reddivari L, Cross TL. A Gnotobiotic Mouse Model with Divergent Equol-Producing Phenotypes: Potential for Determining Microbial-Driven Health Impacts of Soy Isoflavone Daidzein. Nutrients. 2024. doi:10.3390/nu16071079

BibTeX
@article{Leonard2024,
  author = {Leonard, Lindsay M and Simpson, Abigayle M R and Li, Shiyu and Reddivari, Lavanya and Cross, Tzu-Wen L},
  title = {A Gnotobiotic Mouse Model with Divergent Equol-Producing Phenotypes: Potential for Determining Microbial-Driven Health Impacts of Soy Isoflavone Daidzein},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16071079}
}
Kostenlos starten →